MicroRNA-92a as a potential biomarker in diagnosis of colorectal cancer: A systematic review and meta-analysis

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Yang, Xin ^a   Zeng, Zongyue ^a   Hou, Yixuan ^a   Yuan, Taixian ^a   Gao, Chao ^a   Jia, Wei ^a   Yi, Xiaoyan ^a   Liu, Manran ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 92A; UNCLASSIFIED DRUG;

AREA UNDER THE CURVE; ARTICLE; CANCER PATIENT; COLORECTAL CANCER; DIAGNOSTIC ACCURACY; DIAGNOSTIC ODDS RATIO; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; HUMAN; META ANALYSIS; NEGATIVE LIKELIHOOD RATIO; POSITIVE LIKELIHOOD RATIO; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW;

AGED; COLORECTAL NEOPLASMS; GENETIC HETEROGENEITY; HUMANS; MICRORNAS; MIDDLE AGED; PUBLICATION BIAS; REGRESSION ANALYSIS; ROC CURVE; TUMOR MARKERS, BIOLOGICAL;

EID: 84895820213     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0088745     Document Type: Article

References (40)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al. (2011) Global cancer statistics. CA: a cancer journal for clinicians 61: 69-90.
2. Weitz J, Koch M, Debus J, Hohler T, Galle PR, et al. (2005) Colorectal cancer. Lancet 365: 153-165. (Pubitemid 40091806)
3. Gellad ZF, Provenzale D (2010) Colorectal cancer: national and international perspective on the burden of disease and public health impact. Gastroenterology 138: 2177-2190.
4. Collins JF, Lieberman DA, Durbin TE, Weiss DG (2005) Accuracy of screening for fecal occult blood on a single stool sample obtained by digital rectal examination: a comparison with recommended sampling practice. Annals of internal medicine 142: 81-85.
5. Walsh JM, Terdiman JP (2003) Colorectal cancer screening: scientific review. JAMA : the journal of the American Medical Association 289: 1288-1296.
6. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
7. He L, Thomson JM, Hemann MT (2005) A microRNA polycistron as a potential human oncogene. Nature 435: 828-833. (Pubitemid 40839734)
8. Calin GA, Croce CM (2006) MicroRNA signatures in human cancers. Nature reviews Cancer 6: 857-866. (Pubitemid 44629897)
9. Ng EK, Tsui NB, Lam NY (2002) Presence of filterable and nonfilterable mRNA in the plasma of cancer patients and healthy individuals. Clinical chemistry 48: 1212-1217. (Pubitemid 34809828)
10. Silva JM, Rodriguez R, Garcia JM (2002) Detection of epithelial tumour RNA in the plasma of colon cancer patients is associated with advanced stages and circulating tumour cells. Gut 50: 530-534. (Pubitemid 34638874)
11. Lo KW, Lo YM, Leung SF (1999) Analysis of cell-free Epstein-Barr virus associated RNA in the plasma of patients with nasopharyngeal carcinoma. Clinical chemistry 45: 1292-1294. (Pubitemid 29424274)
12. Chen XQ, Bonnefoi H, Pelte MF (2000) Telomerase RNA as a detection marker in the serum of breast cancer patients. Clinical cancer research : an official journal of the American Association for Cancer Research 6: 3823-3826.
13. Wong SC, Lo SF, Cheung MT (2004) Quantification of plasma beta-catenin mRNA in colorectal cancer and adenoma patients. Clinical cancer research : an official journal of the American Association for Cancer Research 10: 1613-1617.
14. Barbarotto E, Schmittgen TD, Calin GA (2008) MicroRNAs and cancer: profile, profile, profile. International journal of cancer Journal international du cancer 122: 969-977.
15. Ng EK, Chong WW, Jin H (2009) Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut 58: 1375-1381.
16. Huang Z, Huang D, Ni S, Peng Z, Sheng W, et al. (2010) Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. International journal of cancer Journal international du cancer 127: 118-126.
17. Giraldez MD, Lozano JJ, Ramirez G (2013) Circulating MicroRNAs as biomarkers of colorectal cancer: Results from a genome-wide profiling and validation study. Clinical Gastroenterology and Hepatology 11: 681-688.e683.
18. Luo X, Stock C, Burwinkel B, Brenner H (2013) Identification and Evaluation of Plasma MicroRNAs for Early Detection of Colorectal Cancer. PLoS One 8.
19. Liu GH, Zhou ZG, Chen R (2013) Serum miR-21 and miR-92a as biomarkers in the diagnosis and prognosis of colorectal cancer. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 34: 2175-2181.
20. Vega AB, Pericay C, Moya I, et al. (2013) microRNA expression profile in stage III colorectal cancer: circulating miR-18a and miR-29a as promising biomarkers. Oncology reports 30: 320-326.
21. Whiting PF, Rutjes AW, Westwood ME, et al. (2011) QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Annals of internal medicine 155: 529-536.
22. Zamora J, Abraira V, Muriel A, Khan K, Coomarasamy A (2006) Meta-DiSc: a software for meta-analysis of test accuracy data. BMC medical research methodology 6: 31.
23. Giraldez MD, Lozano JJ, Ramirez G, Castells A, Gironella M (2011) Plasma microRNAs as a potential strategy for non-invasive colorectal cancer screening. Gastroenterology 140: S410.
24. Sung JJ, Chong WS, Jin H (2009) Differential expression of microRNAs in plasma of colorectal cancer patients: A potential marker for colorectal cancer screening. Gastroenterology 136: A165.
25. Ahmed FE, Amed NC, Vos PW (2012) Diagnostic microRNA markers to screen for sporadic human colon cancer in blood. Cancer genomics & proteomics 9: 179-192.
26. Faltejskova P, Bocanek O, Sachlova M (2012) Circulating miR-17-3p, miR-29a, miR-92a and miR-135b in serum: Evidence against their usage as biomarkers in colorectal cancer. Cancer biomarkers : section A of Disease markers 12: 199-204.
27. Nugent M, Miller N, Kerin MJ (2012) Circulating miR-34a levels are reduced in colorectal cancer. Journal of surgical oncology 106: 947-952.
28. Sterne JA, Gavaghan D, Egger M (2000) Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature. Journal of clinical epidemiology 53: 1119-1129.
29. Glas AS, Lijmer JG, Prins MH, Bonsel GJ, Bossuyt PM (2003) The diagnostic odds ratio: a single indicator of test performance. Journal of clinical epidemiology 56: 1129-1135. (Pubitemid 37386338)
30. Jones CM, Athanasiou T (2005) Summary receiver operating characteristic curve analysis techniques in the evaluation of diagnostic tests. The Annals of thoracic surgery 79: 16-20. (Pubitemid 40037431)
31. Lijmer JG, Bossuyt PM, Heisterkamp SH (2002) Exploring sources of heterogeneity in systematic reviews of diagnostic tests. Statistics in medicine 21: 1525-1537. (Pubitemid 34746061)
32. Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50: 1088-1101.
33. Lee RC, Feinbaum RL, Ambros V (1993) The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75: 843-854. (Pubitemid 24014542)
34. Chen X, Ba Y, Ma L (2008) Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell research 18: 997-1006.
35. Wittmann J, Jack HM (2010) Serum microRNAs as powerful cancer biomarkers. Biochimica et biophysica acta 1806: 200-207.
36. Cortez MA, Bueso-Ramos C, Ferdin J, Lopez-Berestein G, et al. (2011) MicroRNAs in body fluids-the mix of hormones and biomarkers. Nature reviews Clinical oncology 8: 467-477.
37. Mitchell PS, Parkin RK, Kroh EM (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proceedings of the National Academy of Sciences of the United States of America 105: 10513-10518.
38. Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics, 2010. CA: a cancer journal for clinicians 60: 277-300.
39. Thomson DM, Krupey J, Freedman SO (1969) The radioimmunoassay of circulating carcinoembryonic antigen of the human digestive system. Proceedings of the National Academy of Sciences of the United States of America 64: 161-167.
40. Hundt S, Haug U, Brenner H (2007) Blood markers for early detection of colorectal cancer: a systematic review. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 16: 1935-1953.